Zdrowie i gospodarka · 23/03/2005

FDA Releases Guidance for Industry on Pharmacogenomic Data Submissions

The Food and Drug Administration (FDA) has released a guidance document for the pharmaceutical industry, outlining recommendations for submitting pharmacogenomic data to support the development of new drugs. The guidance aims to facilitate scientific progress in the field of pharmacogenomics.